Navigation Links
Siemens and LabCorp Enter Agreement to Co-Develop New Clinical Diagnostic Tests
Date:5/8/2008

ts in America. Together, the companies are well positioned to co-develop and introduce new diagnostic tests that may advance patient care through early detection and proper monitoring of disease.

"This agreement establishes a framework that gives both companies the opportunity to offer new diagnostic tests to laboratories, physicians and their patients more quickly and effectively than either could do alone," said Dave Hickey, senior vice president strategic planning and business development, Siemens Healthcare Diagnostics. "Advancing health care for patients is an important commitment that we can reach through strategic relationships such as this."

"LabCorp is excited about this strategic collaboration and its impact on our companion diagnostics efforts," said Myla P. Lai-Goldman, M.D., executive vice president, chief scientific officer and medical director for LabCorp. "Alliances, such as this between developers and providers of new tests, are critical in translating emerging biomarkers from research into clinical practice."

About Siemens Healthcare

Siemens Healthcare is one of the world's largest suppliers to the healthcare industry. The company is a renowned medical solutions provider with core competence and innovative strength in diagnostic and therapeutic technologies as well as in knowledge engineering, including information technology and system integration. With its laboratory diagnostics acquisitions, Siemens Healthcare will be the first fully integrated diagnostics company, bringing together imaging and lab diagnostics, therapy, and healthcare information technology solutions, supplemented by consulting and support services. Siemens Healthcare delivers solutions across the entire continuum of care -- from prevention and early detection, to diagnosis, therapy and care. The company employs more than 49,000 people worldwide and operates in 130 countries. In the fiscal year 2007 (Sept. 30), Siemens Healthcare reported sales of eur
'/>"/>

SOURCE Siemens Healthcare
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission
2. Siemens Showcases Its Most Comprehensive and Advanced Breast Care Portfolio
3. Siemens Medical Solutions Diagnostics Inks Agreement with KreLo Medical Diagnostics to Expand Thyroid Immunoassay Menu
4. Siemens Healthcare Diagnostics Launches B12, Folate, and Ferritin Tests on Its Dimension vista Intelligent Lab System
5. Alegent Health Sees Positive Results From Recent Clinician Usability Study Collaboration With Siemens and Motion Computing
6. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
7. Kosans Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease
8. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
9. The Heart, Diabetes, And Weight Loss Centers of New York Introduce the New Science of Metabolic Diagnosis and Weight Management
10. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
11. Keeping the Data Center Clean: ATEN Launches Industry-First KVM Switches with Antimicrobial Nanocoating to Protect Products from Bacteria Surviving on Surfaces
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/7/2008)...tudy shows how sounds are amplified in the inner e...can result from genetic mutation or,overdose of dr...re/ -- St. Jude Children,s,Research Hospital inves...mplification mechanism in the cochlea of the ear i...r mammals. The findings will enable better,underst...
(Date:5/7/2008)...ata Presented at American Psychiatric Association ...stCall/ -- Forest Laboratories, Inc.,(NYSE: FRX )...escitalopram,oxalate) significantly improved sympt... and was well tolerated in adolescents, aged 12-17...to phase III data presented at,the 2008 Annual Mee...
(Date:5/7/2008)...o Review CUSTOM III Six-Month Data to be held Tues...ire-FirstCall/ -- XTENT, Inc.,(Nasdaq: XTNT ) tod...e,CUSTOM III trial will be presented at EuroPCR, t... will hold a webcast and conference call to review... late-breaking session. In,addition, two-year CUST...
(Date:5/6/2008)...reliminary Phase 1 and 2 Data Expected at ASCO in ...swire-FirstCall/ -- Poniard,Pharmaceuticals, Inc. ...sed,on oncology, today announced that it has compl...ial evaluating picoplatin combination chemotherapy...ctal cancer (CRC). Early,data from this trial are ...
Breaking Medicine Technology:St. Jude Finds 'Dancing' Hair Cells Are Key to Humans' Acute Hearing 2St. Jude Finds 'Dancing' Hair Cells Are Key to Humans' Acute Hearing 3Study Demonstrates Lexapro(R) Significantly Improves Depression Symptoms in Adolescents 2Study Demonstrates Lexapro(R) Significantly Improves Depression Symptoms in Adolescents 3Study Demonstrates Lexapro(R) Significantly Improves Depression Symptoms in Adolescents 4Study Demonstrates Lexapro(R) Significantly Improves Depression Symptoms in Adolescents 5Study Demonstrates Lexapro(R) Significantly Improves Depression Symptoms in Adolescents 6XTENT Announces Clinical Trial Data to be Presented at Annual EuroPCR Meeting Next Week 2XTENT Announces Clinical Trial Data to be Presented at Annual EuroPCR Meeting Next Week 3XTENT Announces Clinical Trial Data to be Presented at Annual EuroPCR Meeting Next Week 4Poniard Pharmaceuticals Completes Enrollment of Phase 2 Picoplatin Trial in Colorectal Cancer 2Poniard Pharmaceuticals Completes Enrollment of Phase 2 Picoplatin Trial in Colorectal Cancer 3Poniard Pharmaceuticals Completes Enrollment of Phase 2 Picoplatin Trial in Colorectal Cancer 4CV Therapeutics Reports 2007 Fourth Quarter and Full Year Financial Results 3534 1CV Therapeutics Reports 2007 Fourth Quarter and Full Year Financial Results 3534 2CV Therapeutics Reports 2007 Fourth Quarter and Full Year Financial Results 3534 3CV Therapeutics Reports 2007 Fourth Quarter and Full Year Financial Results 3534 4CV Therapeutics Reports 2007 Fourth Quarter and Full Year Financial Results 3534 5CV Therapeutics Reports 2007 Fourth Quarter and Full Year Financial Results 3534 6CV Therapeutics Reports 2007 Fourth Quarter and Full Year Financial Results 3534 7CV Therapeutics Reports 2007 Fourth Quarter and Full Year Financial Results 3534 8Tips for Troublesome Medications From the Harvard Heart Letter 12794 1Tips for Troublesome Medications From the Harvard Heart Letter 12794 2ISS Recommends Pharmion Shareholders Vote for Merger With Celgene 3533 1ISS Recommends Pharmion Shareholders Vote for Merger With Celgene 3533 2ISS Recommends Pharmion Shareholders Vote for Merger With Celgene 3533 3CMC Moffitt Partner to Study Cancer 1435 1CMC Moffitt Partner to Study Cancer 1435 2
...Cancer Research, TARRYTOWN, N.Y., June 15, 2007 /P...announced the results of scientific studies that,(...ive in treating,multiple types of human tumors in ...-6827 exerts its effects, and (3) show that,MPC-68...e involved,in cancer drug resistance. The study re...
...nfluenza Conference, HIGH WYCOMBE, England, June 1...-clinical data showing how a new flu vaccine has t...luenza, including,pandemic and annual, was present...Control of Influenza VI (Options) Conference, in,T...will be published in the,European Journal of Immun...
Other Medicine Technology:New Research Demonstrates Broad Efficacy of Azixa (MPC-6827),Against Multiple Tumor Types and in Drug Resistant Cell Lines 2New Research Demonstrates Broad Efficacy of Azixa (MPC-6827),Against Multiple Tumor Types and in Drug Resistant Cell Lines 3New Research Demonstrates Broad Efficacy of Azixa (MPC-6827),Against Multiple Tumor Types and in Drug Resistant Cell Lines 4New Research Demonstrates Broad Efficacy of Azixa (MPC-6827),Against Multiple Tumor Types and in Drug Resistant Cell Lines 5New Research Demonstrates Broad Efficacy of Azixa (MPC-6827),Against Multiple Tumor Types and in Drug Resistant Cell Lines 6New Flu Vaccine From PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 2New Flu Vaccine From PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 3New Flu Vaccine From PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 4
(Date:5/10/2008)...to play smart to avoid devastating vision injuries...hDay News) -- Every year in the United States, abo...s, says the American Academy of Ophthalmology (AAO...iate, sports-specific eye protection properly fitt...rom polycarbonate materials offer the highest leve...
(Date:5/9/2008)...Calif., May 9 /PRNewswire-USNewsire/ -- U.S.,corpo...to help victims of,the Cyclone Nargis in Myanmar a...lief International, to ensure that the aid will re..., "It,s important to remember the complete story ...rts with the people and organizations that,provide...
(Date:5/9/2008)... May 9 /PRNewswire-USNewswire/ -- Metaverse develo...lieve the unspeakable human,suffering in Myanmar i...sks,have been developed and are being placed in hi...d Life, with coordination being arranged via the,S...p://slurl.com/secondlife/Simuality/106/83/41 )., ...
(Date:5/9/2008)... stimulants a fixture of European nightlife, study... -- Many teens and young adults in Europe are drin... according to a survey of more than 1,300 people w...showed that a third of males and a quarter of fema...chances of sex, while cocaine, ecstasy and cannabi...
Breaking Medicine News(10 mins):Health News:Protective Eyewear Key to Sports Safety 2Health News:Direct Relief's Corporate Partners Key to Aiding Cyclone Victims 2Health News:Young Adults Using Alcohol, Drugs for Better Sex 2
...known to help in controlling obesity. A new study ...urnal of Obesity (2005) says that dietary calcium ...ies and helps in a coordinated increase in lipid u...s. The study took recordings of two groups of ob...
...adding the drug rasagiline to standard treatment w...on’s disease // patients spend suffering from moto...r the study researchers compared once-daily oral r...must be taken with every levodopa dose, and a plac...
...s being hailed by researchers for its ability to t.../. The drug being called ON01910 works by interfer...lls need in order to divide and multiply. This mol...cerous tumors, and people with poorer cancer survi...
... that a new drug named histatin, a naturally occur...Candida albicans,// which is responsible for most ...idiasis, also known as thrush, is a disease charac...the membranes of the mouth, tongue and throat. It ...
Other Medicine News:
Care must be taken to operate the power unit slowly to help eliminate the possibility of breaking the wires by over-tightening.
Large solid mallet with patented Ortho-Grip® silicone rubber handle.
Straight curette with hollow handle and round cup.
Set of 5 large bone curettes. One each of the following: angled small, straight small, angled medium, straight medium, and angled large.
Medicine Products: